Masimo Corporation  

(Public, NASDAQ:MASI)   Watch this stock  
Find more results for MASI
93.54
+0.27 (0.29%)
After Hours: 93.30 -0.24 (-0.26%)
Mar 28, 4:41PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 92.96 - 93.69
52 week 39.53 - 96.68
Open 93.27
Vol / Avg. 642,449.00/1.29M
Mkt cap 4.72B
P/E 16.74
Div/yield     -
EPS 5.59
Shares 50.42M
Beta 1.09
Inst. own 83%
Feb 21, 2017
Q4 2016 Masimo Corp Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '16) 2016
Net profit margin 117.52% 43.28%
Operating margin 169.43% 60.58%
EBITD margin - 24.13%
Return on average assets 118.29% 42.28%
Return on average equity 193.31% 71.96%
Employees 1,243 -
CDP Score - -

Address

52 Discovery
IRVINE, CA 92618-3105
United States - Map
+1-949-2977000 (Phone)
+1-949-2977499 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company's business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include non-invasive monitoring of blood constituents with an optical signature, optical organ oximetry monitoring, electrical, brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring. In addition, the Company has developed the Root patient monitoring and connectivity platform, the Radical-7 bedside and portable patient monitor, and the Radius-7 wearable wireless patient monitor. It offers Patient SafetyNet remote patient surveillance monitoring system, which allows patients to be monitored through a personal computer-based monitor or by care providers through their pagers, voice-over-Internet Protocol (IP) phones or smartphones.

Officers and directors

Joseph E. Kiani Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation  - Reuters
Mark P. de Raad Chief Financial Officer, Executive Vice President - Finance
Age: 56
Bio & Compensation  - Reuters
Jon Coleman President - Worldwide Sales, Professional Services and Medical Affairs
Age: 52
Bio & Compensation  - Reuters
Rick Fishel President, Worldwide OEM Business & Blood Management
Age: 58
Bio & Compensation  - Reuters
Anand Sampath Chief Operating Officer
Age: 49
Bio & Compensation  - Reuters
Yongsam Lee Executive Vice President, Chief Information Officer
Age: 51
Bio & Compensation  - Reuters
Tom McClenahan Executive Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Paul Jansen Executive Vice President - Business Development
Age: 45
Bio & Compensation  - Reuters
Steven J. Barker M.D., Ph.D. Director
Age: 71
Bio & Compensation  - Reuters
Adam P. Mikkelson Director
Age: 38
Bio & Compensation  - Reuters